In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261

European Journal of Neuroscience

Volumn 14, Issue 9, 2001, Pages 1567-1570

  El Yacoubi, Malika ^a   Ledent, Catherine ^b   Parmentier, Marc ^b   Ongini, Ennio ^c,d   Costentin, Jean ^a   Vaugeois, Jean Marie ^a  

^a CNRS   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c San Raffaele Science Park   (Italy)

^d NicOx Research Institute   (Italy)

Author keywords

A2A adenosine receptors; A2A knockout mice; A2A receptor occupancy; Basal ganglia; SCH 58261

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; CAFFEINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HYPOTHALAMUS; IN VIVO STUDY; ISOTOPE LABELING; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PONS; PRIORITY JOURNAL; RADIOACTIVITY; TIME; WILD TYPE;

EID: 0035783886     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2001.01771.x     Document Type: Article

References (29)

1. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci., 19, 9192-9200.
2. 2A adenosine receptor agonists CGS 21680 and HENECA in the rat hippocampus. Br. J. Pharmacol., 122, 1279-1284.
3. 2A receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 261-271.
4. 2A receptors. Br. J. Pharmacol., 129, 1465-1473.
5. 2A receptor. Eur. J. Pharmacol., 401, 63-77.
6. Fredholm, B.B. (1995) Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol., 76, 93-101.
7. 2A receptor antagonist, is a useful ligand in autoradiographic studies. J. Neurochem., 70, 1210-1216.
8. 11C] KF18446 with in vitro autoradiography and in vivo tissue uptake. Ann. Nucl. Med., 14, 81-89.
9. 2 receptors in rat brain. J. Pharmacol. Exp. Ther., 251, 888-893.
10. 3H]CGS 21680. Eur. J. Pharmacol., 168, 243-246.
11. Johansson, B., Georgiev, V., Kuosmanen, T. & Fredholm, B.B. (1996) Long-term treatment with some methylxanthines decreases the susceptibility to bicuculline- and pentylenetetrazol-induced seizures in mice. Relationship to c-fos expression and receptor binding. Eur. J. Neurosci., 8, 2447-2458.
12. 3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur. J. Pharmacol., 247, 103-110.
13. 1 adenosine receptor occupancy. Neuropsychopharmacology, 6, 145-153.
14. 2A receptor. Nature, 388, 674-678.
15. 3H]-CGS 21680 in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 539-541.
16. Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
17. 2A receptor ligand. J. Nucl. Med., 39, 498-503.
18. 2 receptor antagonist, to rat brain membranes. Mol. Pharmacol., 46, 817-822.
19. Olah, M.E. & Stiles, G.L. (2000) The role of receptor structure in determining adenosine receptor activity. Pharmacol. Ther., 85, 55-75.
20. Ongini, E., Dionisotti, S., Gessi, S., Irenius, E. & Fredholm, B.B. (1999) Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 359, 7-10.
21. 2A receptors. Trends Pharmacol. Sci., 17, 364-372.
22. 3H]CGS 21680 as a ligand. Naunyn Schmiedebergs Arch. Pharmacol., 342, 85-89.
23. 2A receptors. Nucl. Med. Biol., 24, 187-191.
24. Svenningsson, P., Hall, H., Sedvall, G. & Fredholm, B.B. (1997) Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study. Synapse, 27, 322-335.
25. 2A receptors. Prog. Neurobiol., 59, 355-396.
26. 2A receptor system using positron emission tomography. J. Med. Chem., 43, 4359-4362.
27. 2A receptors with positron emission tomography. Nucl. Med. Biol., 27, 541-546.
28. 2 receptors. J. Neurosci., 20, 5949-5957.
29. 2A adenosine receptor antagonist, to rat striatal membranes. Br. J. Pharmacol., 117, 1381-1386.